The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease

Huntington’s disease (HD) is a monogenetic neurodegenerative disorder characterized by the accumulation of polyglutamine-expanded huntingtin (mHTT). There is currently no cure, and therefore disease-slowing remedies are sought to alleviate symptoms of the multifaceted disorder. Encouraging findings...

Description complète

Détails bibliographiques

Auteurs principaux:	Elisabeth Singer, Lilit Hunanyan, Magda M. Melkonyan, Jonasz J. Weber, Lusine Danielyan, Huu Phuc Nguyen
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-03-01
Collection:	Pharmaceuticals
Sujets:	Huntington’s disease huntingtin neurodegeneration alpha-2 adrenoceptor beditin autophagy
Accès en ligne:	https://www.mdpi.com/1424-8247/14/3/257
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!